141 related articles for article (PubMed ID: 37032433)
1. Systemic depletion of WWP1 improves insulin sensitivity and lowers triglyceride content in the liver of obese mice.
Nozaki Y; Kobayashi M; Wakasawa H; Hoshino S; Suwa F; Ose Y; Tagawa R; Higami Y
FEBS Open Bio; 2023 Jun; 13(6):1086-1094. PubMed ID: 37032433
[TBL] [Abstract][Full Text] [Related]
2. WWP1 knockout in mice exacerbates obesity-related phenotypes in white adipose tissue but improves whole-body glucose metabolism.
Hoshino S; Kobayashi M; Tagawa R; Konno R; Abe T; Furuya K; Miura K; Wakasawa H; Okita N; Sudo Y; Mizunoe Y; Nakagawa Y; Nakamura T; Kawabe H; Higami Y
FEBS Open Bio; 2020 Mar; 10(3):306-315. PubMed ID: 31965758
[TBL] [Abstract][Full Text] [Related]
3. Identification of WWP1 as an obesity-associated E3 ubiquitin ligase with a protective role against oxidative stress in adipocytes.
Kobayashi M; Hoshino S; Abe T; Okita N; Tagawa R; Nagai W; Konno R; Suzuki Y; Furuya K; Ishikawa N; Okado H; Oku M; Iwamoto M; Miura Y; Sudo Y; Higami Y
Biochem Biophys Res Commun; 2019 Jan; 508(1):117-122. PubMed ID: 30471861
[TBL] [Abstract][Full Text] [Related]
4. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
5. Lack of skeletal muscle liver kinase B1 alters gene expression, mitochondrial content, inflammation and oxidative stress without affecting high-fat diet-induced obesity or insulin resistance.
Chen T; Hill JT; Moore TM; Cheung ECK; Olsen ZE; Piorczynski TB; Marriott TD; Tessem JS; Walton CM; Bikman BT; Hansen JM; Thomson DM
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165805. PubMed ID: 32339642
[TBL] [Abstract][Full Text] [Related]
6. Ube4A maintains metabolic homeostasis and facilitates insulin signaling in vivo.
Mukherjee S; Chakraborty M; Msengi EN; Haubner J; Zhang J; Jellinek MJ; Carlson HL; Pyles K; Ulmasov B; Lutkewitte AJ; Carpenter D; McCommis KS; Ford DA; Finck BN; Neuschwander-Tetri BA; Chakraborty A
Mol Metab; 2023 Sep; 75():101767. PubMed ID: 37429524
[TBL] [Abstract][Full Text] [Related]
7. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
[TBL] [Abstract][Full Text] [Related]
8. Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice.
Costa DK; Huckestein BR; Edmunds LR; Petersen MC; Nasiri A; Butrico GM; Abulizi A; Harmon DB; Lu C; Mantell BS; Hartman DJ; Camporez JP; O'Doherty RM; Cline GW; Shulman GI; Jurczak MJ
Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E105-16. PubMed ID: 27166280
[TBL] [Abstract][Full Text] [Related]
9. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.
Perfield JW; Lee Y; Shulman GI; Samuel VT; Jurczak MJ; Chang E; Xie C; Tsichlis PN; Obin MS; Greenberg AS
Diabetes; 2011 Apr; 60(4):1168-76. PubMed ID: 21346175
[TBL] [Abstract][Full Text] [Related]
10. Hepatic insulin sensitivity is improved in high-fat diet-fed Park2 knockout mice in association with increased hepatic AMPK activation and reduced steatosis.
Edmunds LR; Huckestein BR; Kahn M; Zhang D; Chu Y; Zhang Y; Wendell SG; Shulman GI; Jurczak MJ
Physiol Rep; 2019 Nov; 7(21):e14281. PubMed ID: 31724300
[TBL] [Abstract][Full Text] [Related]
11. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
12. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
[TBL] [Abstract][Full Text] [Related]
13. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
[TBL] [Abstract][Full Text] [Related]
14. Cistanche tubulosa phenylethanoid glycosides suppressed adipogenesis in 3T3-L1 adipocytes and improved obesity and insulin resistance in high-fat diet induced obese mice.
Abudujilile D; Wang W; Aimaier A; Chang L; Dong Y; Wang Y; Fan X; Ma Y; Wang Y; Ziyayiding D; Ma Y; Lv J; Li J
BMC Complement Med Ther; 2022 Oct; 22(1):270. PubMed ID: 36229811
[TBL] [Abstract][Full Text] [Related]
15. Opposing effects of reduced kidney mass on liver and skeletal muscle insulin sensitivity in obese mice.
Chin SH; Item F; Wueest S; Zhou Z; Wiedemann MS; Gai Z; Schoenle EJ; Kullak-Ublick GA; Al-Hasani H; Konrad D
Diabetes; 2015 Apr; 64(4):1131-41. PubMed ID: 25325737
[TBL] [Abstract][Full Text] [Related]
16. Inducible Deletion of Protein Kinase Map4k4 in Obese Mice Improves Insulin Sensitivity in Liver and Adipose Tissues.
Danai LV; Flach RJ; Virbasius JV; Menendez LG; Jung DY; Kim JH; Kim JK; Czech MP
Mol Cell Biol; 2015 Jul; 35(13):2356-65. PubMed ID: 25918248
[TBL] [Abstract][Full Text] [Related]
17. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
18. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.
Korenblat KM; Fabbrini E; Mohammed BS; Klein S
Gastroenterology; 2008 May; 134(5):1369-75. PubMed ID: 18355813
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
20. CTRP7 deletion attenuates obesity-linked glucose intolerance, adipose tissue inflammation, and hepatic stress.
Petersen PS; Lei X; Wolf RM; Rodriguez S; Tan SY; Little HC; Schweitzer MA; Magnuson TH; Steele KE; Wong GW
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E309-E325. PubMed ID: 28223291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
